| GTO ID | GTC2961 |
| Trial ID | NCT05277753 |
| Disease | T-Cell Acute Lymphoblastic Leukemia |
| Therapy | CAR-T cell|CAR-NK cell |
| Treatment | CAR-T/CTL |
| Co-treatment | DCvac cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | NGS-MRD Evaluation of Antigen-specific T Cells and DC Vaccine Combination Targeting T-cell Acute Lymphoblastic Leukemia |
| Year | 2022 |
| Country | China |
| Company sponsor | Shenzhen Geno-Immune Medical Institute |
| Other ID(s) | GIMI-IRB-22002 |
| Cohort 1 | |||||||
|
|||||||